✦ LIBER ✦

Antiglobulin and Anti-Gm Antibodies in Patients with Malignant Tumors

✍ Scribed by P. Gabay; I. Lille-Szyszkowicz; L. Podliachouk; A. Eyquem; J. S. Bourdin; R. T. Saracino

Book ID: 115106592
Publisher: John Wiley and Sons
Year: 1968
Tongue: English
Weight: 128 KB
Volume: 14
Category: Article
ISSN: 0042-9007
DOI: 10.1111/j.1423-0410.1968.tb03411.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gm Groups and Anti-Gm Antibodies in Chil

Gm Groups and Anti-Gm Antibodies in Children with Cooley's Anaemia

✍ Dr. A. Vierucci 📂 Article 📅 1965 🏛 John Wiley and Sons 🌐 English ⚖ 530 KB

Lack of the Induction of Anti-Gangliosid

Lack of the Induction of Anti-Ganglioside GM3 Antibody in the Patients With Malignant Melanoma in Japanese

✍ NAKANO, JUNJI ;YASUI, HIROO ;MUTO, MASAHIKO 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB

Anti-GM1 and anti-myelin antibodies in p

Anti-GM1 and anti-myelin antibodies in patients with the Guillain-Barre syndrome (GBS)

✍ N. Latov; C.L. Koski; E. Nobile-Orazio; S.A. Sadiq; S.K. Dhaliwal; L.H. van den 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Anti-ovarian antibodies in sera of patie

Anti-ovarian antibodies in sera of patients with ovarian tumors

✍ Szubert, Sebastian; Michalak, Slawomir; Szpurek, Dariusz; Moszynski, Rafal; Kryg 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 785 KB

Serum anti-GM1 and anti-GD1a antibodies

Serum anti-GM1 and anti-GD1a antibodies in patients with motor neuron disease

✍ C. Voumvourakis; A. Rombos; M. M. Konstantoulakis; I. Segditsa; C. Papageorgiou 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 491 KB

Gm(1) and Gm(2) immunglobulin allotypes

Gm(1) and Gm(2) immunglobulin allotypes in patients with malignant melanoma

✍ W. Schultheis; H. H. Peter; H. Deicher 📂 Article 📅 1975 🏛 Springer 🌐 English ⚖ 301 KB

Gm allotype markers were determined in sera from 71 melanoma patients and 400 control persons. There was no significant difference between both groups in Gm distribution. The results were compared to a recent report. Furthermore, in 25 malanoma patients the capacity of serum to interfere with cell-m